Life
An important part of medical analysis is looking at illness from an intersectional perspective, in order to understand how racial genetics could contribute to certain cancers — and how that can help target treatment. Studies show that black women have higher breast cancer mortality rates than their peers of other races, particularly of aggressive cancers, and knowing why this racial disparity exists can help researchers figure out how to save the most lives.
Some of the causes behind racial disparity in illness, medical experts point out, are about access to resources and lifestyle choices: if you're in a comparatively less wealthy minority that encounters structural discrimination, earns less, and has less access to good nutrition or medical help, your rates of illness related to lifestyle and early prevention are probably going to be higher. (This is part of the reason why diabetes, for example, is higher among black American and Native American populations than among Caucasians, for instance.) But we're also increasingly uncovering genetic reasoning behind some of these issues, and it's giving a clearer picture of the diversity of the human genome, how race interacts with disease, and why it's so important for treatments to take race into account. For Black women in particular, understanding this phenomenon and how it relates to breast cancer has life-saving implications.
It's Not All About Biology
Figuring out why Black women die more of breast cancer goes beyond genetics, however. The Breast Cancer Research Foundation's 2016 data, which looked at cities and their particular health systems, found something interesting. "Differences in access to public health systems, and hence, differences in access to—and quality of—mammography and treatment are likely contributing to the problem," its author, Dr. Marc Hurlbert, wrote. That's supported by data coming out of the UK. In 2016, Cancer Research UK revealed that Black women in England are almost twice as likely to be diagnosed with advanced breast cancer as white women, and suggested that part of the problem was that Black women feel they have less access to mammograms and cancer screenings. "You'll get leaflets through your door and [the images] will be [of] predominantly of white, middle-class women. There's no representation of South Asian, African descent," a representative of the Black Health Initiative told the BBC.
Other answers are suggested, too. The Guardian reported in 2015 that experts were looking at the rising rates of mortality for breast cancer in Black women through the lens of childbearing choices, obesity, structural inequality, and environmental toxins — but also faced considerable internal disagreement about which of those aspects matter and which don't. Meanwhile, the disparity is likely going to continue to grow. The Center for Disease Control and Prevention notes that while breast cancer deaths themselves are going down, Black women's higher mortality rates don't appear to be shifting.
In light of the data about triple-negative breast cancer and the BRCA1 gene, one of the best ways to help black women seems to be finding a better treatment for the most aggressive types of breast cancer — and fast. A complicated therapy involving a medication known as a PARP inhibitor for triple-negative and basal cell breast cancers may show promise in the future, but isn't widely in use at the moment. Hopefully, though, with more scientists diving into the fray every year, this aspect of the disparity, at least, may one day have a better outcome.